North America Cardiovascular Needle Market Analysis, Size, and Share by 2028

North America Cardiovascular Needle Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Round-Bodied Needles, and Cutting Needles); Application (Open Heart Surgery, and Cardiac Valve Procedures); Usage (Single Use, and Multiple Uses); End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Cardiovascular Centers)

Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028
  • Status : Published
  • Report Code : TIPRE00025905
  • Category : Life Sciences
  • No. of Pages : 104
  • Available Report Formats : pdf-format excel-format
  • Last update date : November 24, 2021
North America Cardiovascular Needle Market Analysis, Size, and Share by 2028
Report Date: November 24, 2021   |   Report Code: TIPRE00025905 Email: sales@theinsightpartners.com

2021 Market Size

US$ 30.55 Mn

Base year value

2028 Forecast

US$ 50.85 Mn

Projected by 2028

CAGR 2022-2028

7.5 %

Growth rate

Addressable Market

US$ 288.59 Mn

(2022-2028)

The cardiovascular needle market in North America is expected to grow from US$ 30.55 Million in 2021 to US$ 50.85 Million by 2028; it is estimated to grow at a CAGR of 7.5% from 2021 to 2028.

Cardiovascular diseases (CVDs) are the disorders of heart and blood vessels, and the category includes cerebrovascular disease, coronary heart disease, rheumatic heart disease, and other conditions. Tobacco consumption, unhealthy diet, and physical inactivity, which increase the risk of heart attacks and strokes, are a few of the major lifestyle factors that lead to the CVDs. Other risk factors causing these diseases include hypertension, diabetes, and increased cholesterol levels. CVDs are among the top 10 causes of death. According to the World Health Organization (WHO), cardiovascular diseases are number one cause of the death. Cardiovascular diseases (CVDs) are likely to remain the largest cause of morbidity and mortality. Fat depositions around blood vessels that prevents blood from flowing to the heart or brain is a main cause of heart attack and stroke. Bleeding vessels or blood clots in brain are a few other causes of stroke. Furthermore, as per the American Heart Association (AHA) 2019 statistics, 121.5 million adults in the US, i.e., ~50% of the US adult population, suffer from CVDs every year. Thus, the significantly rising incidence of CVDs is contributing to the high demand for diagnostic and treatment cardiovascular devices, which is driving the cardiovascular needle market growth.

Cardiac surgical patients not only require vital ICU resources but are also potentially in the highest risk category of complications of COVID-19. Hence, most of the hospitals and surgical enters has considered to cancel or postponed elective surgeries including cardiovascular surgeries. Hence impact of COVID 19 is expected to be somewhat negative on cardiovascular needle market, but it is also anticipated for short term. According to the Society of Thoracic Surgeons Adult Cardiac Surgery Database and Johns Hopkins COVID-19 database, there was a 52.7% reduction in adult cardiac surgery volume and a 65.5% reduction in elective cases in United States. After the first COVID-19 surge, nationwide cardiac surgical case volumes have declined, which indicates a COVID-19-associated impact on cardiac surgery patients. However, in long run, as the vaccination schedule will establishes and transmission rate decreases, healthcare systems will return to normal and will have increased demand for cardiovascular needle, which will support the market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the cardiovascular needle market. The North America cardiovascular needle market is expected to grow at a good CAGR during the forecast period.

North America cardiovascular needle market

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

North America Cardiovascular Needle Market Segmentation    

By Application

  • Open Heart Surgery
  • Cardiac Valve Procedures

By Usage

  • Single Use
  • Multiple Uses

By End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centres
  • Cardiovascular Centres

By Country

  • North America
    • US
    • Canada
    • Mexico

Companies Mentioned

  • Ethicon (Johnson & Johnson Services, Inc.)    
  • MANI, INC         
  • Barber of Sheffield       
  • FSSB surgical needles GmbH    
  • Medtronic         
  • Teleflex Incorporated    
  • Meril Life Sciences Pvt. Ltd.      
  • CP Medical        
  • SMB Corporation of India

North America Cardiovascular Needle Report Scope

Report Attribute Details
Market size in 2021 US$ 30.55 Million
Market Size by 2028 US$ 50.85 Million
CAGR (2021 - 2028) 7.5%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • Round-Bodied Needles
  • Cutting Needles
By Application
  • Open Heart Surgery
  • Cardiac Valve Procedures
By Usage
  • Single Use
  • Multiple Uses
By End User
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Cardiovascular Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Ethicon (Johnson & Johnson Services, Inc.)
  • MANI, INC
  • Barber of Sheffield
  • FSSB surgical needles GmbH
  • Medtronic
  • Teleflex Incorporated
  • Meril Life Sciences Pvt. Ltd.
  • CP Medical
  • SMB Corporation of India
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA